These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Mechanical modulation of atrial flutter cycle length. Ravelli F; Masè M; Disertori M Prog Biophys Mol Biol; 2008; 97(2-3):417-34. PubMed ID: 18359063 [TBL] [Abstract][Full Text] [Related]
29. Electrophysiologic effects of a new class III antiarrhythmic agent, E-4031, on atrial flutter, atrial refractoriness, and conduction delay in a canine sterile pericarditis model. Shimizu A; Kaibara M; Centurion OA; Kapuku G; Hirata T; Fukatani M; Yano K; Hashiba K J Cardiovasc Pharmacol; 1993 Apr; 21(4):656-62. PubMed ID: 7681913 [TBL] [Abstract][Full Text] [Related]
30. Initial clinical experience with a remote magnetic catheter navigation system for ablation of cavotricuspid isthmus-dependent right atrial flutter. Arya A; Kottkamp H; Piorkowski C; Bollmann A; Gerdes-Li JH; Riahi S; Esato M; Hindricks G Pacing Clin Electrophysiol; 2008 May; 31(5):597-603. PubMed ID: 18439175 [TBL] [Abstract][Full Text] [Related]
31. Effects of antiarrhythmic drugs on canine atrial flutter due to reentry: role of prolongation of refractory period and depression of conduction to excitable gap. Inoue H; Yamashita T; Nozaki A; Sugimoto T J Am Coll Cardiol; 1991 Oct; 18(4):1098-104. PubMed ID: 1910060 [TBL] [Abstract][Full Text] [Related]
32. Electropharmacologic effects of class I and class III antiarrhythmia drugs on typical atrial flutter: insights into the mechanism of termination. Tai CT; Chen SA; Feng AN; Yu WC; Chen YJ; Chang MS Circulation; 1998 May; 97(19):1935-45. PubMed ID: 9609087 [TBL] [Abstract][Full Text] [Related]
33. A new methodology for atrial flutter ablation by direct visualization of cavotricuspid conduction with voltage gradient mapping: a comparison to standard techniques. Bailin SJ; Johnson WB; Jumrussirikul P; Sorentino D; West R Europace; 2013 Jul; 15(7):1013-8. PubMed ID: 23447574 [TBL] [Abstract][Full Text] [Related]
34. Celivarone for maintenance of sinus rhythm and conversion of atrial fibrillation/flutter. Khitri AR; Aliot EM; Capucci A; Connolly SJ; Crijns H; Hohnloser SH; Kulakowski P; Roy D; Radzik D; Kowey PR J Cardiovasc Electrophysiol; 2012 May; 23(5):462-72. PubMed ID: 22171925 [TBL] [Abstract][Full Text] [Related]
35. Effect of nifekalant on acute electrical remodelling in rapid atrial pacing canine model. Tang M; Zhang S; Sun Q; Hua W; Huang CX Chin Med J (Engl); 2006 Dec; 119(24):2056-61. PubMed ID: 17199956 [TBL] [Abstract][Full Text] [Related]
36. Azd7009: a new antiarrhythmic drug with predominant effects on the atria effectively terminates and prevents reinduction of atrial fibrillation and flutter in the sterile pericarditis model. Goldstein RN; Khrestian C; Carlsson L; Waldo AL J Cardiovasc Electrophysiol; 2004 Dec; 15(12):1444-50. PubMed ID: 15610294 [TBL] [Abstract][Full Text] [Related]
37. Effect of chronic amiodarone therapy on excitable gap during typical human atrial flutter. Maury P; Zimmermann M J Cardiovasc Electrophysiol; 2004 Dec; 15(12):1416-23. PubMed ID: 15610289 [TBL] [Abstract][Full Text] [Related]
38. Effects of ibutilide on inhibiting heart rate and rapidly terminating atrial flutter in canine. Sun J; Li X; Guo J; Liu P; Zhang P Cell Biochem Biophys; 2011 Apr; 59(3):153-8. PubMed ID: 20972643 [TBL] [Abstract][Full Text] [Related]
39. Functional characterization of the crista terminalis in patients with atrial flutter: implications for radiofrequency ablation. Liu TY; Tai CT; Huang BH; Higa S; Lin YJ; Huang JL; Yuniadi Y; Lee PC; Ding YA; Chen SA J Am Coll Cardiol; 2004 May; 43(9):1639-45. PubMed ID: 15120825 [TBL] [Abstract][Full Text] [Related]
40. Right atrial flutter due to lower loop reentry: mechanism and anatomic substrates. Cheng J; Cabeen WR; Scheinman MM Circulation; 1999 Apr; 99(13):1700-5. PubMed ID: 10190879 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]